ACE2 and cardiovascular disorder: This includes actin and actinin-related proteins (ACTA2, ACTN4), proteins with genetic evidence for involvement in structural cardiovascular disease (BAG3, CDKN1A, NOTCH1, TNNI3), and proteins targeted as biomarkers or treatment of disease (ACE2, BNP, NT-proBNP).